Grail (GRAL) Set to Announce Quarterly Earnings on Tuesday

Grail (NASDAQ:GRAL) will be posting its quarterly earnings results after the market closes on Tuesday, November 12th. Persons that are interested in participating in the company’s earnings conference call can do so using this link.

Grail (NASDAQ:GRAL) last announced its earnings results on Tuesday, August 13th. The company reported ($5.30) earnings per share (EPS) for the quarter. The company had revenue of $31.97 million for the quarter.

Grail Trading Up 1.9 %

Grail stock traded up $0.26 during trading hours on Tuesday, hitting $14.24. 107,845 shares of the company traded hands, compared to its average volume of 1,120,683. The firm’s 50-day moving average price is $13.65. Grail has a 1-year low of $12.33 and a 1-year high of $23.36.

Wall Street Analysts Forecast Growth

Separately, Guggenheim initiated coverage on Grail in a report on Thursday, October 17th. They set a “neutral” rating on the stock.

Insider Activity

In other news, major shareholder Chun R. Ding acquired 7,629 shares of the business’s stock in a transaction dated Tuesday, October 1st. The stock was acquired at an average price of $13.52 per share, for a total transaction of $103,144.08. Following the completion of the acquisition, the insider now directly owns 3,503,655 shares in the company, valued at $47,369,415.60. This represents a 0.00 % increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through this link. In related news, major shareholder Chun R. Ding purchased 16,200 shares of the company’s stock in a transaction on Wednesday, October 9th. The shares were bought at an average price of $12.92 per share, with a total value of $209,304.00. Following the completion of the acquisition, the insider now owns 3,644,855 shares of the company’s stock, valued at approximately $47,091,526.60. This represents a 0.00 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, major shareholder Chun R. Ding acquired 7,629 shares of the business’s stock in a transaction dated Tuesday, October 1st. The shares were bought at an average price of $13.52 per share, with a total value of $103,144.08. Following the transaction, the insider now directly owns 3,503,655 shares in the company, valued at approximately $47,369,415.60. The trade was a 0.00 % increase in their position. The disclosure for this purchase can be found here. In the last ninety days, insiders have bought 58,829 shares of company stock worth $757,298.

Grail Company Profile

GRAIL, Inc, a biotechnology company, focuses on developing technologies for early cancer detection. The company develops Galleri, a screening test for asymptomatic individuals over 50 years of age; and DAC, a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients for whom there is a clinical suspicion of cancer.